Stay updated on ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial page.

Latest updates to the ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision history now shows the latest version as v3.3.2, replacing v3.2.0, which reflects a site version update rather than changes to study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedRemoval of the government funding/operating status banner from the page; this is an administrative notice and does not affect the study record or core content.SummaryDifference0.6%

- Check42 days agoChange DetectedThe two screenshots show the same Record History page with the same version entries; any differences seem limited to visual layout rather than substantive updates.SummaryDifference0.1%

- Check71 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus a version bump to v3.2.0.SummaryDifference12%

- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.3%

- Check92 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' element.SummaryDifference0.7%

Stay in the know with updates to ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial page.